P. Aebischer et al., FUNCTIONAL RECOVERY IN HEMIPARKINSONIAN PRIMATES TRANSPLANTED WITH POLYMER-ENCAPSULATED PC12 CELLS, Experimental neurology, 126(2), 1994, pp. 151-158
Cross-species neural grafting of cell lines immunoisolated by a permse
lective polymer membrane represents a promising source of neuroactive
molecules for the treatment of neurodegenerative diseases. Utilization
of a cell line of xenogeneic origin is advantageous since the transpl
anted cells will be rejected by the host immune system in case of brea
kage of the immunoisolating envelope. Polymer-encapsulated PC12 cells,
a dopaminergic cell line derived from a rat pheochromocytoma, were tr
ansplanted in five Macaca fascicularis monkeys which had been previous
ly rendered hemiparkinsonian by a unilateral carotid injection of 1-me
thyl-4-phenyl- 1,2,3,6-tetrahydropyridine. Well-preserved, tyrosine hy
droxylase positive encapsulated PC12 cells were observed in the lesion
ed striatum for up to 5 months after implantation. Four out of five mo
nkeys which received polymer-encapsulated PC12 cells showed significan
t behavioral improvement, whereas three monkeys implanted with either
encapsulated bovine chromaffin cells or empty polymer envelopes showed
no amelioration. (C) 1994 Academic Press, Inc.